Pharma
Resolving a critical manufacturing line issue
Background
Innovation is the lifeblood of the pharmaceutical industry; new drugs drive growth and offset generic competition as patents expire. Each day’s delay in launching costs approximately £650,000 in lost sales.
Challenge
A critical defect at a costly end-of-line stage was identified during a Product Performance Qualification (PPQ) run. The high speed of the production line made pinpointing the precise issue difficult. Product release deadlines were under threat.
- A significant fault emerged at a costly, high-stakes stage of production
- The rapid pace of production made it difficult to locate and diagnose the issue accurately
- Delays risked missing launch schedules, with substantial financial implications
- Each day’s delay represented approximately £650,000 in lost sales, increasing pressure to act quickly
Solution
PurpleSector deployed its non-invasive, high-speed machine vision sensors.
The F1™-derived cameras captured two hours of footage which PurpleSector then analysed with its bespoke performance measurement algorithm.
.avif)
Results
By swiftly identifying and resolving the critical defect, we helped the client achieve zero wastage.
The root cause was identified within an hour and promptly rectified. Subsequent PPQ runs were completed without issues, ensuring the drug was available to patients when required.
Latest News
Interested to hear more?
Fill in your details and we’ll keep you up to date with our latest projects.
Services
Our Services
We deploy F1™ - derived tools, technologies and techniques to help organisations operate like an F1™ team. Our goal is to build the in-house capability for clients to solve challenges, uncover opportunities and deliver performance gains at race-pace.
Get in touch
